Limo Chen

4.0k total citations · 2 hit papers
26 papers, 1.9k citations indexed

About

Limo Chen is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Limo Chen has authored 26 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Oncology and 8 papers in Immunology. Recurrent topics in Limo Chen's work include Cancer Immunotherapy and Biomarkers (8 papers), Lung Cancer Research Studies (4 papers) and Immunotherapy and Immune Responses (4 papers). Limo Chen is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Lung Cancer Research Studies (4 papers) and Immunotherapy and Immune Responses (4 papers). Limo Chen collaborates with scholars based in United States, China and Mexico. Limo Chen's co-authors include Don L. Gibbons, Lauren A. Byers, Lixia Diao, Jing Wang, Ignacio I. Wistuba, John V. Heymach, B. Leticia Rodriguez, Edwin R. Parra, Carmen Behrens and Yongbin Yang and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Limo Chen

25 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting DNA Damage Response Promotes Antitumor Immunity through STING-Mediated T-cell Activation in Small Cell Lung Cancer

2019 616 citations Triparna Sen, B. Leticia Rodriguez et al. Cancer Discovery profile →
Epithelial–Mesenchymal Transition Is Associated with a Distinct Tumor Microenvironment Including Elevation of Inflammatory Signals and Multiple Immune Checkpoints in Lung Adenocarcinoma

2016 349 citations Yanyan Lou, Lixia Diao et al. Clinical Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Limo Chen United States	18	1.0k	816	712	276	257	26	1.9k
Chie Kudo‐Saito Japan	22	1.2k 1.2×	793 1.0×	968 1.4×	303 1.1×	327 1.3×	41	2.0k
Li-Chuan Chan Taiwan	17	1.2k 1.2×	965 1.2×	779 1.1×	425 1.5×	406 1.6×	27	2.1k
Maciej Kmieciak United States	24	971 1.0×	849 1.0×	876 1.2×	149 0.5×	225 0.9×	66	2.0k
Anna E. Vilgelm United States	23	1.0k 1.0×	773 0.9×	630 0.9×	283 1.0×	196 0.8×	48	1.9k
Justin M. David United States	18	769 0.8×	543 0.7×	558 0.8×	218 0.8×	211 0.8×	30	1.4k
Joe Stephenson United States	25	1.1k 1.1×	894 1.1×	429 0.6×	488 1.8×	360 1.4×	65	2.0k
Sandra Cristea United States	8	898 0.9×	906 1.1×	344 0.5×	207 0.8×	173 0.7×	9	1.5k
Viia Valge-Archer United Kingdom	19	1.0k 1.0×	1.1k 1.3×	1.2k 1.7×	130 0.5×	373 1.5×	27	2.4k
Eva M. Garrido‐Martín Spain	19	545 0.5×	615 0.8×	617 0.9×	306 1.1×	164 0.6×	36	1.6k
Rodabe N. Amaria United States	21	1.4k 1.4×	776 1.0×	563 0.8×	286 1.0×	110 0.4×	117	1.8k

Countries citing papers authored by Limo Chen

Since Specialization

Citations

This map shows the geographic impact of Limo Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Limo Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Limo Chen more than expected).

Fields of papers citing papers by Limo Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Limo Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Limo Chen. The network helps show where Limo Chen may publish in the future.

Co-authorship network of co-authors of Limo Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Limo Chen. A scholar is included among the top collaborators of Limo Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Limo Chen. Limo Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rodriguez, B. Leticia, Limo Chen, Yanli Li, et al.. (2023). Targeting immunosuppressive Ly6C+ classical monocytes reverses anti-PD-1/CTLA-4 immunotherapy resistance. Frontiers in Immunology. 14. 1161869–1161869. 5 indexed citations

Yang, Hongwei, Ting Chen, Séverine Denoyelle, et al.. (2022). Role of symmetry in 3,3-diphenyl-1,3-dihydroindol-2-one derivatives as inhibitors of translation initiation. Bioorganic & Medicinal Chemistry Letters. 80. 129119–129119. 1 indexed citations

Peng, David H., B. Leticia Rodriguez, Lixia Diao, et al.. (2021). Th17 cells contribute to combination MEK inhibitor and anti-PD-L1 therapy resistance in KRAS/p53 mutant lung cancers. Nature Communications. 12(1). 2606–2606. 53 indexed citations

Peng, David H., B. Leticia Rodriguez, Lixia Diao, et al.. (2020). Collagen promotes anti-PD-1/PD-L1 resistance in cancer through LAIR1-dependent CD8+ T cell exhaustion. Nature Communications. 11(1). 4520–4520. 292 indexed citations

Sen, Triparna, B. Leticia Rodriguez, Limo Chen, et al.. (2019). Targeting DNA Damage Response Promotes Antitumor Immunity through STING-Mediated T-cell Activation in Small Cell Lung Cancer. Cancer Discovery. 9(5). 646–661. 616 indexed citations breakdown →

Li, Yanli, Tingting Wu, Yanan Wang, et al.. (2018). γ-Glutamyl cyclotransferase contributes to tumor progression in high grade serous ovarian cancer by regulating epithelial-mesenchymal transition via activating PI3K/AKT/mTOR pathway. Gynecologic Oncology. 149(1). 163–172. 24 indexed citations

Chen, Limo, Lixia Diao, Yongbin Yang, et al.. (2017). Abstract 567: CD38 blockade overcomes the immune resistance to anti-PD-L1 therapy by boosting CD8 T cell response. Cancer Research. 77(13_Supplement). 567–567.

Sen, Triparna, Limo Chen, B. Leticia Rodriguez, et al.. (2017). Abstract B72: Combining immune checkpoint inhibition and DNA damage repair (DDR) targeted therapy in small cell lung cancer (SCLC). Cancer Immunology Research. 5(3_Supplement). B72–B72. 3 indexed citations

Lou, Yanyan, Lixia Diao, Edwin R. Parra, et al.. (2016). Epithelial–Mesenchymal Transition Is Associated with a Distinct Tumor Microenvironment Including Elevation of Inflammatory Signals and Multiple Immune Checkpoints in Lung Adenocarcinoma. Clinical Cancer Research. 22(14). 3630–3642. 349 indexed citations breakdown →

10.

Chen, Limo, Xiaohui Yi, Sangeeta Goswami, et al.. (2016). Growth and metastasis of lung adenocarcinoma is potentiated by BMP4-mediated immunosuppression. OncoImmunology. 5(11). e1234570–e1234570. 22 indexed citations

11.

Fan, Qiong, Zhu Zhu, Suet‐Ying Kwan, et al.. (2015). KDM4B and KDM4A promote endometrial cancer progression by regulating androgen receptor, c-myc, and p27kip1. Oncotarget. 6(31). 31702–31720. 26 indexed citations

12.

Chen, Limo, John V. Heymach, F. Xiao‐Feng Qin, & Don L. Gibbons. (2015). The mutually regulatory loop of epithelial–mesenchymal transition and immunosuppression in cancer progression. OncoImmunology. 4(5). e1002731–e1002731. 23 indexed citations

13.

Chen, Ting, Rupam Sahoo, Limo Chen, et al.. (2014). 3‐Substituted Indazoles as Configurationally Locked 4EGI‐1 Mimetics and Inhibitors of the eIF4E/eIF4G Interaction. ChemBioChem. 15(4). 595–611. 16 indexed citations

14.

Gibbons, Don L., Limo Chen, Sangeeta Goswami, et al.. (2014). Regulation of tumor cell PD-L1 expression by microRNA-200 and control of lung cancer metastasis.. Journal of Clinical Oncology. 32(15_suppl). 8063–8063. 7 indexed citations

15.

Denoyelle, Séverine, Ting Chen, Hongwei Yang, et al.. (2013). Synthesis and SAR study of novel 3,3-diphenyl-1,3-dihydroindol-2-one derivatives as potent eIF2·GTP·Met-tRNAiMet ternary complex inhibitors. European Journal of Medicinal Chemistry. 69. 537–553. 20 indexed citations

16.

Chen, Limo, Bertal H. Aktas, Yibo Wang, et al.. (2012). Tumor suppression by small molecule inhibitors of translation initiation. Oncotarget. 3(8). 869–881. 85 indexed citations

17.

Denoyelle, Séverine, Ting Chen, Limo Chen, et al.. (2011). In vitro inhibition of translation initiation by N,N′-diarylureas—potential anti-cancer agents. Bioorganic & Medicinal Chemistry Letters. 22(1). 402–409. 46 indexed citations

18.

Chen, Ting, Yuan Qiao, Fred Harbinski, et al.. (2011). Chemical genetics identify eIF2α kinase heme-regulated inhibitor as an anticancer target. Nature Chemical Biology. 7(9). 610–616. 95 indexed citations

19.

Chen, Limo, Linjie Guo, Jun Tian, et al.. (2010). Overexpression of CXC Chemokine Ligand 14 Exacerbates Collagen-Induced Arthritis. The Journal of Immunology. 184(8). 4455–4459. 27 indexed citations

20.

Chen, Limo. (2005). Reversal of the phenotype byK-ras^val12silencing mediated by adenovirus-delivered siRNA in human pancreatic cancer cell line Panc-1. World Journal of Gastroenterology. 11(6). 831–831. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact